Immupharma (IMM)

 58.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 99.50p
  • 52 Week Low: 57.00p
  • Currency: UK Pounds
  • Shares Issued: 81.53m
  • Volume: 3,100
  • Market Cap: £47.90m
  • RiskGrade: 161
  • Beta: 0.09

Immupharma Overview

Immupharma is in the pharmaceuticals & biotechnology sector and is currently trading at 58.75p per share. In the last year Immupharma's share price has ranged from 57.00p to 99.50p and brokers are currently rating this stock as 'buy'.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.4%
Div Cover n/a n/a
Op Mrgn -22770.2% -1401.9%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2843.3 1306.4
Pr/Book 3.8  
Latest F'cast
Revenue -48.1% 117.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Immupharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 0.06 (3.34) (4.24)p n/a n/a n/a n/a 0.0%
31-Dec-08 0.06 4.86 6.23p 9.1 n/a n/a n/a 0.0%
31-Dec-09 22.05 9.10 10.46p 9.1 0.1 +68% n/a 0.0%
31-Dec-10 0.03 (2.47) (2.44)p n/a n/a n/a n/a 0.0%
31-Dec-11 0.02 (3.61) (4.12)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Immupharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 0.04 (0.51) (0.59)p n/a n/a n/a 0.25p 0.4%
31-Dec-13 0.04 (1.36) (0.32)p n/a n/a n/a 0.50p 0.8%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Immupharma Company Announcements

Annual General Meeting: 2012 23-May-2012 12:20 RNS
Posting of Annual Report and AGM Notice 17-Apr-2012 07:00 RNS
Preliminary Results 27-Mar-2012 07:00 RNS

Latest Immupharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Immupharma Market Data

Currency UK Pounds
Share Price 58.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 99.50p
52 Week Low 57.00p
Volume 3,100
Shares Issued 81.53m
Market Cap £47.90m
Beta 0.09
RiskGrade 161

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.28% below the market average45.28% below the market average45.28% below the market average45.28% below the market average45.28% below the market average
19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average
Price Trend
65.17% below the market average65.17% below the market average65.17% below the market average65.17% below the market average65.17% below the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average
Income Not Available
Growth
4.32% below the market average4.32% below the market average4.32% below the market average4.32% below the market average4.32% below the market average
10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 1
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Immupharma Dividends

No dividends found

Trades for 31-May-2012

Time Volume / Share Price
09:47 3,100 @ 57.64p

Immupharma Key Personnel

Chair Richard Warr
CEO Dimitri Dimitriou

Top of Page